Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hematuria Evaluation by Whole-genome Sequencing of Urine-Exfoliated Cell DNA, A Prospective, Multi-center Study

NCT05893316 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT05893316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hematuria Evaluation by Whole-genome Sequencing of Urine-Exfoliated Cell DNA, A Prospective, Multi-center Study
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2023
Completion date
February 1, 2024
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematuria, urothelial carcinoma